Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R W Jayne

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Cleveland Clinic Journal of Medicine|June 28, 2002
Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitisDavid R W Jayne
Kidney International|February 21, 2013
Antineutrophil cytoplasm antibody-associated vasculitis: recent developmentsShunsuke Furuta, David R W Jayne
Rheumatology (Oxford, England)|December 25, 2009
Long-term treatment of relapsing Wegener's granulomatosis with 15-deoxyspergualinOliver Flossmann, David R W Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2019
Estimating the epidemiology of anti-neutrophil cytoplasm antibody-associated renal vasculitis and the role of histologic chronicity in predicting renal outcomesAndreas Kronbichler, David R W Jayne
Nephron. Clinical Practice|November 16, 2005
Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitisMaria Koukoulaki, David R W Jayne
Annals of the Rheumatic Diseases|December 30, 2025
Recent pathogenetic insights and therapeutic advances in ANCA-associated vasculitisIftach Sagy, David R W Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 16, 2013
Impact of rituximab trials on the treatment of ANCA-associated vasculitisFederico Alberici, David R W Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2015
Opponent's commentsAndreas Kronbichler, David R W Jayne
Nature Clinical Practice. Rheumatology|July 24, 2008
Maintaining remission in a patient with vasculitisOliver Flossmann, David R W Jayne
Kidney International|November 24, 2018
ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?Andreas Kronbichler, David R W Jayne
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Cleveland Clinic Journal of Medicine|June 28, 2002
Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitisDavid R W Jayne
Kidney International|February 21, 2013
Antineutrophil cytoplasm antibody-associated vasculitis: recent developmentsShunsuke Furuta, David R W Jayne
Rheumatology (Oxford, England)|December 25, 2009
Long-term treatment of relapsing Wegener's granulomatosis with 15-deoxyspergualinOliver Flossmann, David R W Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2019
Estimating the epidemiology of anti-neutrophil cytoplasm antibody-associated renal vasculitis and the role of histologic chronicity in predicting renal outcomesAndreas Kronbichler, David R W Jayne
Nephron. Clinical Practice|November 16, 2005
Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitisMaria Koukoulaki, David R W Jayne
Annals of the Rheumatic Diseases|December 30, 2025
Recent pathogenetic insights and therapeutic advances in ANCA-associated vasculitisIftach Sagy, David R W Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 16, 2013
Impact of rituximab trials on the treatment of ANCA-associated vasculitisFederico Alberici, David R W Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2015
Opponent's commentsAndreas Kronbichler, David R W Jayne
Nature Clinical Practice. Rheumatology|July 24, 2008
Maintaining remission in a patient with vasculitisOliver Flossmann, David R W Jayne
Kidney International|November 24, 2018
ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?Andreas Kronbichler, David R W Jayne
Pageof 16